Flutinorm-S 250 Inhacaps is a combination inhalation capsule containing Salmeterol (50mcg) and Fluticasone Propionate (250mcg), designed for the management of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta2-adrenergic receptor agonist that helps relax the muscles in the airways, leading to bronchodilation and improved airflow. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, thereby decreasing the frequency and severity of asthma attacks and exacerbations of COPD. The dual action of Flutinorm-S 250 Inhacaps provides both immediate relief of bronchospasm and long-term control of airway inflammation. This medication is typically prescribed for patients who require maintenance treatment to prevent symptoms such as wheezing, shortness of breath, and coughing. It is important to use Flutinorm-S 250 Inhacaps regularly as directed by a healthcare professional, even when symptoms are not present, to achieve optimal control of respiratory conditions. Patients should be advised on proper inhalation technique and informed about potential side effects, including oral thrush, hoarseness, and increased heart rate. Flutinorm-S 250 Inhacaps should not be used for acute asthma attacks and requires medical supervision during use.